ABC arbitrage SA (0OPJ)
London Exchange · UK · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 5.640 |
|---|---|
| 52-week range | 4.793 – 5.900 |
| Return, 1 month / 3 months | +6.6% / +11.0% |
| Return, 1 year / 3 years | −2.3% / +14.8% |
| Trend | Uptrend |
| RSI (14) | 52 |
| Volatility (1 year) | 21.5% |
| Worst drawdown (1 year) | -14.7% |
| Average daily value traded | 0.01M EUR |
| Dividend yield | 4.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
ABC arbitrage is a French investment firm based in Paris that specialises in arbitrage strategies. It uses quantitative and statistical methods to trade across equities and related instruments, seeking returns that are largely independent of overall market direction. The company manages its own capital and funds for institutional and individual investors, and its activities centre on market-neutral approaches designed to capture pricing differences between related securities.
The shares are listed on the London Exchange in UK under the code 0OPJ, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
ABC arbitrage SA (0OPJ) trades on the London Exchange in UK. It last closed at EUR 5.640 on 19 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 801 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 2.3% and over the last three months it rose 11.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 68 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 6.4% | ||
| From 52-week high | -4.4% | ||
| Momentum | 72 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 11.0% | ||
| 6-month return | 7.8% | ||
| 12-month return, skipping the last month | – | ||
| Stability (higher is calmer) | 85 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 21.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -14.7% | ||
| Liquidity | 12 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M EUR | ||
| Zero-volume days | 11.7% | ||
| Income | 83 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 4.3% | ||
| Years with dividends | 6 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −1.2% |
|---|---|
| 1 month | +6.6% |
| 3 months | +11.0% |
| 6 months | +7.8% |
| 1 year | −2.3% |
| 3 years | +14.8% |
| 5 years | – |
Signals
| 50-day / 200-day average | 5.414 / 5.299 |
|---|---|
| Golden / death cross (60 days) | Golden, 12 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.062 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 Jul 2026 | EUR 0.0400 |
| 14 Apr 2026 | EUR 0.1000 |
| 2 Dec 2025 | EUR 0.1000 |
| 7 Oct 2025 | EUR 0.1000 |
| 8 Jul 2025 | EUR 0.0400 |
| 22 Apr 2025 | EUR 0.1000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.